Table 4.
Variable | 6-Months outcomes Z scores
|
12-Months outcomes Z scores
|
||||
---|---|---|---|---|---|---|
Cancer-specific distress | General distress | Genetic-testing distress | Cancer-specific distress | General distress | Genetic-testing distress | |
Associated baseline variablea | ||||||
Men | 3.66*** | 1.77c | 3.37*** | 4.44*** | 2.74** | 4.73*** |
Women | 6.30*** | 3.58*** | 4.77*** | 6.22*** | 3.09** | 3.22** |
Family history totalb | ||||||
Men | 0.85 | 0.73 | 0.30 | −1.54 | 0.09 | 1.26 |
Women | 1.62c | 1.88c | 0.13 | 0.71 | −0.26 | −0.37 |
Having daughters (vs. not) | ||||||
Men | 0.08 | 1.38 | 1.42 | 0.46 | 0.10 | 1.76c |
Women | 1.04 | 0.25 | 0.06 | 1.43 | −0.07 | −0.20 |
Married (vs. not) | ||||||
Men | −1.11 | −1.55 | −1.32 | 1.90c | 0.05 | −2.18* |
Women | −0.24 | −0.80 | −0.53 | −1.55 | −1.78c | −1.68 |
Jewish ethnicity (vs. not) | ||||||
Men | 1.12 | 0.93 | 1.78c | 1.52 | −0.23 | 0.68 |
Women | 2.74** | 1.99* | 1.40 | 1.26 | −0.85 | −0.22 |
Annual income ≥ $75,000 (vs. not) | ||||||
Men | 1.19 | 1.60 | 1.55 | −1.15 | 1.81c | 1.14 |
Women | 1.05 | 0.26 | −0.45 | 0.58 | −1.01 | −0.06 |
Employed full-time (vs. not) | ||||||
Men | −1.21 | 1.39 | 0.62 | −0.16 | 1.80c | −0.26 |
Women | −0.67 | −0.98 | −1.50 | −0.79 | −1.52 | −1.47 |
Study site (GU vs. NY/NJ) | ||||||
Men | 0.96 | 0.46 | 0.31 | 0.37 | 1.47 | 1.67c |
Women | 2.21* | 1.54 | 0.92 | 1.48 | −0.21 | 0.27 |
We included the baseline variable associated with the specified outcome within the general estimating equation models. For genetic testing distress, we used cancer-specific distress at baseline, as we did not have a baseline measure of genetic testing distress
Family history total represents the total number of first and second degree relatives diagnosed with breast or ovarian cancer
P < 0.10
P < 0.05;
P < 0.01;
P < 0.001